We use cookies to give you a better Web experience. By visiting our website you agree to our use of cookies. Read about cookies
OK
  1. Home
  2. Mandates
  3. Vinge has advised Vicore Pharma in connection with a directed share issue of approximately SEK 125 million

Assignment Vinge has advised Vicore Pharma in connection with a directed share issue of approximately SEK 125 million

November 13, 2019

Vinge has advised Vicore Pharma, a Swedish rare disease company focused on interstitial lung diseases and related indications, in connection with a directed share issue whereby Vicore Pharma will receive approximately SEK 125 million in issue proceeds.

The subscription price was determined to SEK 16 per share through an accelerated book building process. The share issue was directed to a number of Swedish and international institutional investors. The main purpose of the share issue is to finance Vicore Pharma’s development of current and future product candidates. 
Vinge’s team consisted of Jesper Schönbeck, Nils Fredrik Dehlin and Stephanie Stiernstedt.

 

Share

Employment law podcast – our first episode in English

 By popular request, here is our very first English-language episode of Vinge's employment law podcast Arbetsrättspodden.
November 28, 2019

Viveka Classon new partner in Stockholm

 Viveka Classon has been elected as a new partner at Vinge’s Stockholm office.
November 14, 2019

Maria-Pia Hope wins the Swedish Bar Association’s award for outstanding work within the legal profession

 For the eighth year in a row, the Swedish Bar Association has issued the award for outstanding achievements within the legal profession. In 2019, the award goes to Maria-Pia Hope, Managing Partner at Advokatfirman Vinge.
October 25, 2019